iPSCs derived from somatic cells through a novel reprogramming method. © UCLA Broad Stem Cell Research Center/Plath Lab

Bayer has widened its pipeline in neurology, cardiology, and immunology by acquiring induced pluripotent stem cell specialist BlueRock Therapeutics.

Circulating tumor DNA (ctDNA) is found in serum and plasma fractions from blood. The exact  mechanism of ctDNA release is unknown. Once ctDNA is isolated, it can be sequenced for mutational analysis. © Creative commons licence, RachelJuneWong

Using a platform tailored to patients’ specific cancer mutations, British and US researchers for the first time detected residual disease in breast cancer patients.

Waste carbon streams as resources for Lanzatech's process. © Lanzatech
Novo Holdings A/S (Novo Holdings) invests $72m in LanzaTech to support development of the company’s sustainable fuels and chemicals platform
With the "BigStitcher" software you can reconstruct a sample and then rotate and turn it virtually, get an overview of the big picture or zoom into individual structures. This works both as a user, as illustrated here, and as an algorithm that analyzes the data and cannot load the entire image into RAM. Neurons expressing a specific gene are marked in green. Such data now make it possible for the first time to systematically characterize differences at the single-cell level between normal and genetically modified mice and to draw conclusions about potential behavioral changes that may result. © Preibisch Lab / Treier Lab, MDC
German researchers have developed a software that allows to manage and correct the huge amount of data generated by 3D reconstruction of tumours or organs using light sheet microscopy.
Vaccinia virus. © wikipedia/commons PHIL

SillaJen, the licensor for French immunoncology specialist Transgene SA, has stopped enrolment into the Phase III Phocus trial after an Independent Data Review Comittee predicted the study endpoint won’t be met.

Wellington Partner's Managing Partner Rainer Strohmenger. © UroMems

Wellington Partners has closed its largest Life Sciences Fund ever. The VC specialist outperformed its intial target of raising €120m to €150m and closed at €210m.

© pixabay/julientromeur

Venture Captital specialist LSP led a €67m Series A financing in peptide developer Alizé Pharma 3.

Microscopic images of either wild type (left) or mutant (right) HeLa cells treated with TNF-alpha.
© P.E. Morton et al., Science Signaling (2019)

Two research teams have unraveled the complex dynamics of TNF? receptor signaling and have identified compounds that may be safer than current treatments.

Agrosavfe's agrocapsules are made by coupling stable camelid agrobodies to microcapsules containing active substances to protect seeds, crops and produce from weeds, pests and diseases. © AgroSavfe NV

Plant protection specialist AgroSavfe will use the funds of a €35m Series C financing to push the development, registration and commercial scale production of its biofungicides and bio-insecticide.

Level of concern associated with GMO content in food and drinks. © Eurobarometer /European Commission

The European Commission has authorised ten genetically modified products.